Real world effectiveness of antipneumococcal vaccination against pneumonia in adults: a population-based cohort study, Catalonia, 2019
This study did not find evidence of the clinical effectiveness of PPsV23/PCV13 vaccination in preventing the outcomes measured at population-based level. At present, new extended-valency, PCVs (PCV15/PCV20/PCV21) have been marketed for using in adults and, logically, vaccines' effectiveness must be re-evaluated in the coming years.
Authors
- Cinta de Diego‐Cabanes (ORCID: https://orcid.org/0000-0001-7801-067X)
- Eva M. Satué-Gracia
- Leonardo de Esteban-Júlvez
- Verónica Torras-Vives (ORCID: https://orcid.org/0000-0003-0939-9049)
- Cruz M Fuentes-Bellido
- Ángel Vila-Córcoles (ORCID: https://orcid.org/0000-0002-1644-0188)
- Frederic Gómez‐Bertomeu (ORCID: https://orcid.org/0000-0002-8039-2889)
- Clara Rodríguez-Casado
- Olga Ochoa‐Gondar (ORCID: https://orcid.org/0000-0002-7015-0018)
- María-José Forcadell-Peris
- Anna Ribes-Alcover
Institutions
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (ES)
- Hospital Universitari Joan XXIII de Tarragona (ES)
- Institut Català de la Salut (ES)
- Institut Català d'Arqueologia Clàssica (ES)
- Universitat Rovira i Virgili (ES)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1186/s12879-025-11596-w
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Generalitat de Catalunya
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III